3
Announcements
Trials
Browse
Landscape
Status
Completed
10
Terminated
8
Withdrawn
3
Recruiting
2
Active not recruiting
2
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma of Lung
1
Interventions
ceritinib
2
taletrectinib
1
sotorasib
1
rociletinib
1
pegilodecakin
1
dabrafenib
1
capmatinib
1
brigatinib
1
belagenpumatucel L
1
alectinib
1
Crizotinib
1
BID protein, human
1
AM0010
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
Carcinoma, Non-Small-Cell Lung
×
capmatinib
×
Clear all
NCT04741789
2026-03-16
Managed Access Programs for INC280, Capmatinib
Novartis
No longer available